Home Title

Transforming lives by delivering convenience through specialist expertise.

Transforming lives by delivering convenience through specialist expertise.

Transforming lives by delivering convenience through specialist expertise.

AGM

The 2020 Annual General Meeting (AGM) of Allergy Therapeutics plc is due to be held electronically on Tuesday 8 December 2020 at 2:00 p.m. The Board is arranging a listen-only conference call facility to allow shareholders to dial in to the AGM and follow proceedings remotely.

Dial in to the conference call
+7% Revenue growth at constant (and 6% at reported rate)
25% Increase in pre-R&D operating profit to £14.2m (2019: £11.3m)
£37.0m Strong cash balance at 30 June 2020 (2019: £27.4m)
£7.1m Net profit for the year including one-off legal settlement of £3.2m (2019: £3.5m)

Our year in numbers

2020 was another year of growth, with a record level of pre R&D operating profit (25%) supported by robust sales and operational efficiencies.

Annual Report 2020

Take your career to new heights

Our culture and values